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The objective of the present work is to develop the stripping voltammetric method for determination of
nephrotoxic drug ceﬁtizoxime in pharmaceutical formulation and its application to wastewater analysis.
Solubilized system of different surfactants viz. cationic, anionic and non-ionic inﬂuences the electro-
chemical response of ceﬁtizoxime. Solubilized system of CTAB containing ceﬁtizoxime enhanced the peak
current while anionic and non-ionic showed an opposite effect. The current signal due to the reduction
process is a function of concentration of the ceﬁtizoxime, pH of medium, type of surfactant and
accumulation time at electrode surface. The proposed SWCAdSV (Squarewave Cathodic Adsorptive
Voltammtery) and DPCAdSV (Differential Pulse Cathodic Adsorptive Voltammetry) are linear over con-
centration range 1.732–6.901 lg/mL and 4.792–30.672 lg/mL with detection limit of 0.76 ng/mL and
2.63 ng/mL, respectively. The method is successfully applied for determination of ceﬁtizoxime in phar-
maceutical formulation and wastewater with mean percentage recovery of 99.73% and 98.51%,
respectively.
 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction Recent advances in technology have allowed the developmentPharmaceuticals are an important group of emerging contami-
nants in the environment [1]. Many drug residues have been found
in water and analysis of drug residues is increasing in importance
day by day [2]. Pharmaceuticals are manufactured each year and
by consumption or improper disposal, they end up in wastewater.
Often wastewater treatment plants cannot degrade these sub-
stances and so loads of pharmaceuticals end up in the environ-
ment. Only recently, the attention has been drawing towards this
pollution in the environment. In recent years, many reports have
been made on the occurrence of the large, differentiated group of
pharmaceuticals in wastewater, surface water, ground water and
in soil [3–5]. Acute toxicity is the biggest concern we are facing
and these biologically active chemicals can have acute effects on
aquatic plants and organisms [6].
The political world has also noticed the problem of pharmaceu-
tical pollution in the environment. Two directives have been writ-
ten (2001/83/EC for human pharmaceuticals, 2001/82/EC for
animal pharmaceuticals) to demand an environmental assessment
for the approval of new drugs coming on the market [7,8]. In this
regard, there has to be made a lot of effort concerning research
toward environmental assessment of pharmaceuticals.of beta-lactams that were too reactive to be isolated in the early
decades of the antibiotic era, but unfortunately also increase their
toxic side effects. Although the penicillins are almost completely
free of renal toxicity, several cephalosporins and most of the
broadly effective beta-lactam antibiotics developed so far are
nephrotoxic [9–13]. This toxicity has been severe enough with cer-
tain cephalosporins to preclude their clinical use. Administration of
nephrotoxic beta-lactam antibiotics cause acute proximal tubular
necrosis.
Ceﬁtizoxime sodium is a sterile, semisynthetic, beta-lacta-
mase resistant antibiotic, having high bactericidal activity
against streptococci, staphylococci, proteus and shigella [14].
This broad-spectrum compound has a synmethoxyimino chain
at the 7-position that confers, 3-lactamase stability [15]. The
bactericidal action of ceﬁtizoxime results from inhibition of
cell-wall synthesis [16].
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estimation of ceﬁtizoxime, these include liquid chromatography
[17], high performance liquid chromatography [18] and high per-
formance liquid chromatography with anion-exchange extraction
technique [19].
The interest in developing electrochemical sensing devices for
use in environment monitoring, clinical assays or process control
is growing rapidly. Electroanalytical techniques have long been
used for the determination of a wide range of drug compounds
with the advantages that there is no need for derivatizations and
these techniques are less sensitive to matrix effects compared to
other analytical techniques [20,21].
Solubilized system of surfactants heavily inﬂuences the electro-
chemical processes of electroactive species [22] and is widely used
in electroanalytical chemistry to improve the sensitivity and selec-
tivity [23,24]. The aggregates of surfactants, such as micelles, liquid
crystalline, vesicles, etc. could enhance the stabilized content and
the control of release behavior of drugs are widely studied as drug
delivery systems. The uses of surfactants as drug carriers make
necessary to the study the interaction of drugs with micellar sys-
tems, implying the elucidation of the nature of these interactions.
In addition, micellar systems are considered primitive model sys-
tems for biological membranes [25]. The current electroanalytical
research is based on voltammetric determination of nephrotoxic
drug ceﬁtizoxime in pharmaceutical formulation and waste water
in presence of less hazardous surfactant media comparison to toxic
organic solvents.2. Experimental
2.1. Materials and methods
Ceﬁtizoxime (99% purity) is obtained from Glaxo SmithKline
Pharmaceuticals and is used as received. Injection containing
ceﬁtizoxime (ceﬁzox) labeled 1.0 g is obtained from commercial
sources. KCl (1.0 mol/L) solution was prepared in double distilled
water and used as supporting electrolyte. All chemicals used are
of analytical reagent grade quality and were employed without
further puriﬁcation.2.2. Procedure
2.2.1. Ceﬁtizoxime measurement in pharmaceutical formulation
A stock solution of ceﬁtizoxime (1.0 mg/mL) was prepared in
DMF, cetyltrimethyl ammonium bromide (CTAB), sodium dodecyl
sulfate (SDS) and in Tween 20. Solution is introduced into a
10 mL volumetric ﬂask and then completed to a volume with a
B–R buffer of selected pH value and 1.0 mol/L KCl. The solution
was transferred into the voltammetric cell, and a pure nitrogen
stream was passed for 5 min before analysis. The analyte was pre-
concentrated by accumulation parameters; tacc = 140 s and
Eacc = 0.5 V while stirring the solution. At the end of the precon-
centration time the stirring was stopped and 5 s were allowedTable 1
Comparison between electrochemical parameters of ceftizoxime in 4.0  103 mol/L CTAB
Operational method 4.1 lg/mL ceﬁtizoxime + 4.0  103 mol/L
aIpc/lA bEpc/V vs.
CV 0.92 1.28
SWV 1.20 1.29
DPV 0.28 1.26
a Cathodic peak current.
b Cathodic peak potential.for the solution to become quiescent. Then the voltammograms
are recorded by scanning the potential towards the negative direc-
tion under the optimized instrumental and operational parameters
(frequency = 100 Hz, scan increment = 10 mV and pulse
height = 50 mV).
2.2.2. Ceﬁtizoxime analysis in wastewater
Wastewater samples were collected from municipal discharge
station in Gwalior city Madhya Pradesh, India and ﬁltered through
Whatman ﬁlter paper. A stock solution of ceﬁtizoxime 1.0 mg/mL
was prepared in industrial wastewater samples to give a ﬁnal con-
centration over the range 2.13–28.48 lg/mL. Other optimization
parameters are same as above for analysis of ceﬁtizoxime in
wastewater.
Cefitizoxime concentration ¼ Cstd  Isamp=Aistd
where Cstd is the concentration of the standard and Isamp and Astd are
the currents for sample and standard, respectively.
2.3. Instrumentation
Electrochemical measurements were performed using a
l-Autolab type III (Eco-Chemie B.V., Utrecht, The Netherlands)
potentiostat–galvanostat with 757VA computrace software. The
utilized electrodes are hanging mercury drop electrode (HMDE)
as working electrode, graphite rod as counter electrode and
Ag/AgCl (3.0 mol/L KCl) as reference electrode. The electrochemical
cell is a Metrohm 663 VA stand. All pH-metric measurements were
made on a Decible DB-1011 digital pH meter ﬁtted with a glass
electrode and a saturated calomel electrode as reference, which
was previously standardized with buffers of known pH.
Chromatographic experiments are performed on the HPLC
apparatus comprised of UV variable wavelength Model SPD-20AU
Prominence (Shimadazu Corporation Japan), Isocratic Pump
LC-20AD Prominence, a Model 7125 injection valve with a 20 lL
sample loop (Rheodyne, Cotati, CA, USA). Data acquisition and
processing are performed by Spinchrom CFR. Injection is accom-
plished with a 20 lL loop injector (Model 701 syringe 50 lL;
Hamilton, Bonaduz, Switzerland). ODS column (250 mm  4.6 mm
i.d., 5 lm) YMC is used for separation. Elution was isocritical at a
ﬂow-rate of 1.5 mL/min and the eluent is monitored at 310 nm.3. Results and discussion
3.1. Ceﬁtizoxime measurement in solubilized system
On comparing the voltammetric behavior (CV (Cyclic
Voltammetry), DPV (Differential Pulse Voltammetry), SWV
(Square Wave Voltammetry)) of ceﬁtizoxime in DMF and in
solubilized system of CTAB (Table 1), it is observed that ceﬁti-
zoxime shows substantial increase in peak current and the limit
of detection is found to be lower in CTAB (Fig. 1) while neutral
and anionic surfactants showed an opposite effect. The reason forand in DMF using different voltammetric methods.
CTAB 4.1 lg/mL ceﬁtizoxime + DMF
Ag/AgCl aIpc/lA bEpc/V vs. Ag/AgCl
0.62 1.23
0.89 1.22
0.23 1.22
Fig. 1. Comparison between voltammograms of 4.2 lg/mL ceﬁtizoxime in 4.0  103 mol/L CTAB (B) and in DMF (A); a (CV), b (SW), c (DPV).
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of ceﬁtizoxime on the electrode surface, which leads to formation
of self-micelle aggregate with CTAB. The adsorption of amphiphilic
species on the electrode surface result in changing the overpoten-
tial of the electrochemical process and rate of its corresponding
charge transfer that affect the mass transport of the electroactive
species [26,27].Fig. 2. Effect of CTAB concentration on SWCAdSV peak current of 6.2 lg/mL
ceﬁtizoxime.3.2. Effect of CTAB concentration
The cathodic peak current increases steadily in the beginning
with increase in concentration of CTAB and reaches a maximum
at 4.0  103 mol/L CTAB (Fig. 2). It may be interpreted that at
4.0  103 mol/L CTAB, the adsorption behavior changes from
monomer adsorption to monolayer adsorption. The peak current
decrease as further increase in CTAB concentration, it is causedby the micelle effect i.e. electron transfer between ceﬁtizoxime
and electrode surface would be inhibited by aggregates of micelles.
Another reason for decrease in peak current is due to increase of
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fer rate constant [28] and result in the decline of peak current at
rather high CTAB concentration. Thus, CTAB concentration of
4.0  103 mol/L can furthest enhances the electrochemical signal
of ceﬁtizoxime.
3.3. Effect of pH
Preliminary experiments were carried out in different support-
ing buffers (phosphate, acetate, borate and citrate) at different pH
values in order to assess their impact on the monitored electroana-
lytical signal. The best results with respect to sensitivity accompa-
nied with sharper response were obtained with B–R buffers. Thus
study was made in the pH range 2.0–12.0 in B–R buffers at a target
concentration of 6.4 lg/mL ceﬁtizoxime in 4.0  103 mol/L CTAB.
The dependence of peak potential to the pH suggests an overall
electrode process involved a proton transfer (Fig. 3).
The relation between Ep of the wave and pH of the medium over
the range 2.0–12.0 is expressed by the following equations:
SWCAdSV : Ep=V ðvs:Ag=AgClÞ¼0:0534þ1:356pH; r2¼0:996
DPCAdSV : Ep=V ðvs:Ag=AgClÞ ¼ 0:0562þ 1:566pH; r2 ¼ 0:991
The height of peak reaches a maximum at pH 10.0. Therefore,
pH 10.0 is chosen as the optimum one for the determination of
ceﬁtizoxime.
3.4. Optimization of operational parameters
In order to obtain the maximum peak current, the optimum
instrumental parameters; accumulation time (tacc), accumulation
potential (Eacc), pulse amplitude (DEsw), scan increment (Ds) and
frequency (f) are examined using the selected waveforms. The
SWCAdSV voltammetric peak current is linearly dependent on
the frequency 40–140 Hz while a well-deﬁned peak was observed
at 100 Hz. The peak potential (Ep) shifted towards more negative
values with increase of frequency. The plot of Ep versus log f [29]
was a straight line following the relation Ep/V = 0.64 log f + 1.23,
the value of ana for the electrode reaction is calculated and found
to equal to 0.165. Since na = 2, a value of transfer coefﬁcient
a = 0.082 is obtained. Although the response to ceﬁtizoxime isFig. 3. Inﬂuence of pH on the cathodic adsorptive peak current response for 6.2 lg/
mL ceﬁtizoxime in B–R buffer (pH 2.0–12) after 140 s pre-concentration time;
frequency (f) = 100 Hz, Ds = 10 mV and pulse amplitude = 50 mV at Eacc = 0.5 V.
Table 2
Analytical parameters for voltammetric determination of ceﬁtizoxime using SWCAdSV an
Method Conc. range (lg/mL) Regression equations (Ipa vs.
SWCAdSV 1.73–6.95 Ip = 2.6  103 Ceftz.  0.045
DPCAdSV 4.79–30.67 Ip = 7.3  102 Ceftz. + 0.054
a Peak current in lA.
b Concentration of ceﬁtizoxime in lg/mL.
c Standard deviation of intercept of regression equation.increased with frequency, but above 100 Hz the peak current is
obscured by a large residual current. The effect of scan increment
on adsorptive cathodic peak current of the drug revealed that the
peak current enhanced upon increase of scan increment (2–
10 mV). At pulse amplitude 50 mV, the peak current is found to
be much sharp and well deﬁned. Thus the best peak deﬁnition is
recorded using 100 Hz frequency, 10 mV scan increment and
50 mV pulse amplitude.
3.4.1. Effect of accumulation potential
The inﬂuence of accumulation potential (Eacc) on the cathodic
peak current (Ip) of 6.4 lg/mL ceﬁtizoxime is examined over the
potential range 0.1 V to 1.2 V. The adsorbed species are most
probably neutral molecules of drug species and the maximum peak
current is achieved in potential range of zero charge of mercury
electrode. At more cathodic values, a decrease in peak current is
observed indicating the drug is no longer strongly adsorbed at
potentials where the mercury is negatively charged with respect
to the zero charge potential. Thus maximum development of the
peak current is achieved at 0.5 V.
3.4.2. Effect of accumulation time
The effect of accumulation time for 6.4 lg/mL ceﬁtizoxime is
investigated from 0 to 350 s. It is observed that peak current
increases with increase in accumulation time up to 140 s indicat-
ing the enhancement of ceﬁzox concentration at the electrode sur-
face. As further increase in the accumulation time the current ﬁrst
decreases and then tends to level off showing that the adsorptive
equilibrium is reached.
3.5. Validation of method
The analytical method was validated with respect to parame-
ters such as limit of quantitation (LOQ), limit of detection (LOD),
precision, accuracy, robustness and ruggedness [30,31].
3.5.1. Linearity range
The linearity of technique is evaluated by linear regression
analysis, which is calculated by least square regression method
[32,33]. The calibration curve constructed for ceﬁtizoxime is linear
over the concentration range 1.732–6.901 lg/mL for SWCAdSV and
4.792–30.672 lg/mL for DPCAdSV. The calibration graph was
represented by the following equation:
SWCAdSV : Ip=lA ¼ ð2:6 103Þ Ceftz:ðlg=mLÞ  ð0:045Þ;
r2 ¼ 0:997; n ¼ 3
DPCAdSV : Ip=lA ¼ ð7:3 102Þ Ceftz:ðlg=mLÞ þ ð0:054Þ;
r2 ¼ 0:996; n ¼ 3
The regression plots showed that there was a linear dependence
of the current intensity on the ceftizoxime concentration in both
DPCAdSV and SWCAdSV modes over the range is given in Table 2.
3.5.2. Detection and quantiﬁcation limit
The detection limit is calculated by equation [34]:d DPCAdSV.
Cb) Sac LOD (ng/mL) LOQ (ng/mL)
2.0  104 0.76 2.63
3.0  104 2.53 8.79
Fig. 4. Cyclic voltammograms of 4.2 lg/mL ceﬁtizoxime containing 4.0  103 mol/
L CTAB in B–R buffer (pH 10.0) at a scan rate of 100 mV/s, equilibrium time = 10 s.
Curve (2) after preconcentration and (1) curve shows 0 s preconcentration.
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where Sa is the standard deviation of intercept and b is the slope of
the regression line. The calculated LOD values of ceﬁtizoxime are
0.76 ng/mL and 2.63 ng/mL for SWCAdSV and DPCAdSV at an
accumulation time of 140 s.
The quantitation limits are estimated by equation:
LOQ ¼ 10Sa=b
The calculated LOQ values are 2.53 ng/mL and 8.76 ng/mL for
SWCAdSV and DPCAdSV respectively.
3.5.3. Accuracy and precision
The accuracy of the analysis was determined by calculating the
percentage relative error between the measured mean concentra-
tion and the nominal concentration [35]. The precision of the
analysis was determined by calculating the relative standard
deviation (%RSD). The precision around the mean should not
exceed 15% of the RSD [36]. The recovery studies are performed
for both pharmaceutical formulation and wastewater (Table 3).
The results obtained indicate the high accuracy and precision of
the proposed method.
3.5.4. Robustness
The robustness is examined by evaluating the inﬂuence of small
variation of some of the most important procedure variables
including pre-concentration potential (Eacc) and pre-concentration
time (tacc). The obtained results provide an indication of the relia-
bility of the proposed procedure for the assay of ceﬁtizoxime in
pharmaceutical formulation and wastewater and hence it can be
considered robust.
3.6. Cyclic voltammetric measurement
The cyclic voltammograms of 4.2 lg/mL ceﬁtizoxime in
4.0  103 mol/L CTAB (pH 10.0) exhibits a single well deﬁned
peak in the potential range 1.1 to 1.46 V, at all concentrations
due to the reduction of –C@N– group which is not accompanied
by corresponding anodic one, indicates the irreversibility of elec-
trode process.
The interfacial accumulation of ceﬁtizoxime can be observed
from cyclic voltammograms in Fig. 4 (curve 1), without preconcen-
tration, and after a preconcentration step (0.5 V, 140 s) Fig. 4
(curve 2). The peaks obtained without accumulation and after a
preconcentration step indicates that ceﬁtizoxime adsorbs readily
at the electrode surface and a considerable increase in sensitivity
can be gained by adsorptive accumulation prior to the voltammet-
ric determination.
The electrode surface coverage (To mol cm2) with ceﬁtizoxime
species is determined from the amount of charge (Q) consumed
by the surface process as calculated by the integration of the area
under the cyclic voltammetric peak of ceﬁtizoxime using the equa-
tion To = Q/nFA, where n is the number of electrons consumed in
the reduction process (n = 2), F is the faraday constant
(96,485 C mol1) and A is the electrode surface area (0.026 cm2).Table 3
Accuracy, precision and recovery of ceﬁtizoxime in pharmaceutical formulation (ceﬁzox) a
Added (lg/mL) Found (lg/mL)
Ceﬁzox 2.25 2.27
3.25 3.27
5.46 5.34
Wastewater 2.25 2.21
3.25 3.19
5.46 5.42
a [(Found  added)/added]  100.On dividing the number of coulombs transferred 794.3 C by the
conversion factor nFA (50,273  109), a monolayer surface cover-
age of 1.52  1010 mol/cm2 is obtained. Thus each absorbed ceﬁti-
zoxime molecule occupies an area of 1.04 nm2.
3.6.1. Effect of scan rate
The effect of scan rate (t1/2) on stripping peak current (Ip) is
examined under the above experimental conditions (Fig. 5). As
the sweep rate is increased from 100 to 300 mV/s at a ﬁxed con-
centration of ceﬁtizoxime, the peak potential shifted to a more
negative value conﬁrming the irreversible nature of the reduction
process [37].
According to the Randles–Sevcik equation in a linear diffusion-
controlled process, Ip / t1/2, for the adsorptive process, Ip / t. The
cathodic peak currents are linearly proportional to scan rate with
a correlation coefﬁcient of 0.994 as shown in inset (A) of Fig. 5
under these conditions currents are adsorption controlled, which
may be expressed by the equation:
Ip=nA ¼ 1:64t ðmV=sÞ þ 384; r2 ¼ 0:994
The adsorption effect was also identiﬁed by a plot of log Ip vs.
log t giving a straight line which can be expressed by the equation:
log Ip=nA ¼ 0:986 log t ðmV=sÞ  1:15; r2 ¼ 0:995
A slope of 0.98 which is closes the theoretical value of 1.0, indi-
cating the adsorptive nature of the reduction process [38,39].nd wastewater by SWCAdSV (n = 3).
RSD (%) aBias (%) % Recovery
1.85 0.80 100.8
1.28 0.61 100.6
0.62 2.10 97.8
1.61 1.77 98.2
0.92 1.84 98.1
0.51 0.73 99.2
Fig. 5. Cyclic voltammograms of 4.2 lg/mL ceﬁtizoxime in 4.0  103 mol/L CTAB
at different scan rates; (a) 100 mV/s, (b) 150 mV/s, (c) 200 mV/s, (d) 250 mV/s, (e)
300 mV/s at Eacc = 0.5 V, tacc = 140 s.
Fig. 6. The dependence of the SWCAdS voltammetric current for ceﬁtizoxime at
different concentrations; in CTAB, Eacc = 0.5 V, tacc = 140 s, frequency f = 100 Hz,
pulse amplitude DEsw = 50 mV and scan increment Ds = 10 mV. (a) Blank, (b)
1.72 lg/mL, (c) 2.64 lg/mL, (d) 3.64 lg/mL, (e) 4.21 lg/mL, (f) 4.98 lg/mL, (g)
6.13 lg/mL, (h) 6.90 lg/mL.
Table 4
Determination of ceﬁtizoxime in ceﬁzox tablets by the proposed HPLC method.
Label claim (mg) Proposed HPLC method
Meana Error (%) RSD (%)
10 mg 10.02 1.20 2.30
20 mg 19.87 0.80 1.87
a Mean of three determinations of each strength.
Fig. 7. Representative chromatogram of 4.2 lg/mL ceﬁtizoxime in pharmaceutical
formulation (ceﬁzox; phosphate buffer pH 7.0) using YMC ODS column
(250 mm  4.6 mm, 5 lm) at a ﬂow rate of 2.0 ml/min monitored at 310 nm by
SPD-20AU detector.
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scan rate of 100 mV/s is illustrated in inset (B) of Fig. 5. The Tafel
plot having the value of 2.3 RT/anF for a reduction reaction [40].
A slope of 0.357 V/decade is obtained and based on this slope;
the value of ana is calculated to be 0.165.
3.7. Analytical applications
3.7.1. Ceﬁtizoxime in dosage form
The proposed analytical method is developed for determination
of drug in pharmaceutical formulation (ceﬁzox). Voltammograms of
ceﬁtizoxime in CTAB exhibit well-deﬁned cathodic peak due to
reduction of –C@N– group. The current is mainly adsorption-con-
trolled and proportional to the concentration over a convenient
range. Statistical evaluation of the experimental data regarding
S.D. of intercept (Sa) gave the value cited in the same Table 2.
The small values point out to the high precision of the method.
The good linearity of the calibration graph and the negligible scat-
ter of the experimental points are clearly evident by the correlation
coefﬁcients. Representative Squarewave voltammograms of ceﬁti-
zoxime are shown in Fig. 6. The proposed procedure is also applied
to the analysis of ceﬁzox injection using DPCAdSV.
3.7.2. Ceﬁtizoxime in wastewater
Recoveries of ceﬁtizoxime from wastewater samples were
determined by the SWCAdSV procedure. An accurately known vol-
ume of the ceﬁtizoxime solution was added to the industrial water
samples. Mean recovery of ceﬁtizoxime from wastewater samples
is 98.51%, indicating good efﬁciency of voltammetric procedure
(Table 3).
4. Chromatography
For chromatographic studies, the mobile phase consisted of
65 mL of acetonitrile and 14 mL of glacial acetic acid diluted to aﬁnal volume of 500 mL with distilled water. The ﬂow rate was
1.5 mL/min, and the eluant is monitored at 310 nm. The experi-
mental details for chromatographic system were based on assay
method mentioned in European Pharmacopoeia. The assay results
are tabulated in Table 4. Fig. 7 shows representative chromatogram
of 4.2 lg/mL of ceﬁtizoxime in pharmaceutical formulation
(ceﬁzox; phosphate buffer pH 7.0) at retention time of 5.27 min.
The HPLC method was used for detection of ceﬁtizoxime.
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The use of solubilized system of surfactants affects the reduc-
tion peak current according to the nature of charge of the surfac-
tant’s polar group. The developed method with the detection
limit of 0.76 ng/mL in solubilized system of CTAB is more sensitive
than already reported chromatographic methods [17–19]. In con-
clusion, above method offers a practical potential for the
determination of ceﬁtizoxime in pharmaceutical formulation and
wastewater especially with its advantages of acceptable sensitiv-
ity, linear dynamic range and simplicity that were not present in
previously reported methods. The main advantage of this new
method is the use of less hazardous surfactant media in place of
organic solvents. The proposed method can be successfully
adopted for the recovery of toxic drugs in wastewater.Conﬂict of interest
Please see acknowledgment section.Acknowledgments
The authors thank the Municipal Committee of Gwalior city for
providing us industrial wastewater for analysis. The authors also
thank the Glaxo SmithKline Pharmaceutical Limited for providing
us ceﬁtizoxime standard.References
[1] S.E. Jorgensen, B. Halling-Sorensen, Drugs in the environment, Chemosphere
40 (2000) 691–699.
[2] K. Kummerer, A. Al-Ahamed, B. Bertram, M. Wiessler, Biodegradability of
antineoplastic compounds in screening tests: inﬂuence of glucosidation and of
stereochemistry, Chemosphere 40 (2000) 767–773.
[3] P.E. Stackelberg et al., Persistence of pharmaceutical compounds and other
organic wastewater contaminants in a conventional drinking-water treatment
plant, Sci. Total Environ. 329 (2004) 99–113.
[4] T. Heberer, Occurrence, fate, and removal of pharmaceutical residues in the
aquatic environment: a review of recent research data, Toxicol. Lett. 131
(2002) 5–17.
[5] A.H. Jones, N. Voulvoulis, J.N. Lester, Predicted and measured concentrations
for selected pharmaceuticals, Crit. Rev. Toxicol. 34 (2004) 335–350.
[6] EC, Directive 2001/82/EC of the European Parliament and the Council of 6
November 2001 on the Community code relating to veterinary medicinal
products, Ofﬁcial Journal No. L311/67, 2001a.
[7] EC, Directive 2001/82/EC of the European Parliament and of the Council of 6
November 2001 on the Community code relating to human medicinal
products, Ofﬁcial Journal No. 311/1, 2001b.
[8] G.L. Mandell, The Cephalosporins, Principles and Practices of Infectious
Diseases, John Wiley and Sons Inc., New York, 1979.
[9] J. Birnbaum, F.M. Kahan, H. Kropp, J.S. MacDonald, Carbapenems, a new class of
beta-lactam antibiotics. Discovery and improvement of imipenem/cilastatin,
Am. J. Med. 78 (1985) 3–21.
[10] B.M. Tune, The nephrotoxicity of beta-lactam antibiotics, in: J.B. Hook, R.S.
Goldstein (Eds.), Toxicology of the Kidney, Raven, New York, 1993.
[11] J.C. Topham, L.B. Murgatroyd, D.V. Jones, U.R. Goonetilleke, J. Wright, Safety
evaluation of meropenem in animals: studies on the kidney, J. Antimicrob.
Chemother. 24 (1989) 287–306.
[12] M. Brughera, G. Scampini, M.L. Ferrari, A. Nava, Â.G. Mazue, Toxicologic proﬁle
of FCE 22101 and its orally available ester FCE 22891, J. Antimicrob.
Chemother. 23 (1989) 129–135.[13] Y. Hirouchi, H. Naganuma, Y. Kawahara, R. Okada, A. Kamiya, K. Inui, R. Hori,
Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems
in rabbit renal cortex, J. Pharmacol. 66 (1994) 1–6.
[14] R.L. Thompson, Cephalosporin, carbapenem and monobactam antibiotics,
Mayo Clin. Proc. 62 (1987) 821–834.
[15] N.J. Montvale, Physicians’ Desk Reference, 46th ed., 1992.
[16] S.L. Barriere, J.F. Flaherty, Third generation cephalosporins, a critical
evaluation, Clin. Pharm. 3 (1984) 351–373.
[17] K.A. Caprile, The cephalosporin antimicrobial agents: a comprehensive review,
J. Vet. Pharmacol. Ther. 11 (1988) 1–32.
[18] Ellen M. Mc cormick, Roger M. Echols, Thomas G. Rosano, Liquid
chromatographic assay of ceftizoxime in sera of normal and uremic patients,
J. Antimicrob. Chemother. 25 (1984) 336–338.
[19] M. Lebel, J.F. Ericson, D.H. Pitkin, Improved high-performance liquid
chromatographic (HPLC) assay method for ceftizoxime, J. Liq. Chromatogr.
Related Technol. 7 (1984) 961–968.
[20] E. Fasching, L. Peterson, Comparison of azlocillin, ceftizoxime, cefoxitin, and
amikacin alone and in combination against Pseudomonas aeruginosa in a
neutropenic-site rabbit model, J. Antimicrob. Chemother. 25 (1984) 545–552.
[21] J.M. Kauffmann, J.C. Vire, Pharmaceutical and biomedical applications of
electroanalysis: a critical review, Anal. Chim. Acta 273 (1993) 329–334.
[22] R. Jain, M. Ritesh, A. Dwivedi, Effect of surfactant on voltammetric behaviour of
ornidazole, Colloids Surf. A: Physicochem. Eng. Aspects 3 (2009) 74–79.
[23] A.P. Doe Reis, C.R.T. Tarley, N. Maniasso, L.T. Kubota, Exploiting micellar
environment for simultaneous electrochemical determination of ascorbic acid
and dopamine, Talanta 67 (2005) 829–835.
[24] D. Attwood, A.T. Florence, Surfactant Systems, Their Chemistry, Pharmacy and
Biology, Chapman and Hall, London, 1983.
[25] M. Makino, M. Kamiya, N. Nakajo, K. Yoshikawa, Effects of local anesthetics on
the dynamic behavior of phospholipid thin ﬁlm, Langmuir 12 (1996) 4211–
4217.
[26] J. Kostela, M. Elmgren, P. Hansson, M. Almgren, Study of cathodic dissolution of
an aluminum wire electrode using ac resistometry, J. Electroanal. Chem. 536
(2002) 97–107.
[27] D.E. Ormonde, R.D. O’Neill, The oxidation of ascorbic acid at carbon paste
electrodes: modiﬁed response following contact with surfactant, lipid and
brain tissue, J. Electroanal. Chem. 279 (1990) 109–121.
[28] A.P. Abbott, G. Gounili, J.M. Bbbitt, J.F. Rusling, Electron transfer between
amphiphilic ferrocenes and electrodes in cationic micellar solutions, J. Phys.
Chem. 96 (1992) 11091–11095.
[29] M. Lovric, S. Komorsky-Lovric, R.W. Merray, Adsorption effects in square-wave
voltammetry of totally irreversible redox reactions, Electrochem. Acta 33
(1988) 739–744.
[30] J. Ermer, Validation in pharmaceutical analysis. Part I: an integrated approach,
J. Pharm. Biomed. Anal. 24 (2001) 755–767.
[31] G.A. Shabir, Validation of high-performance liquid chromatography methods
for pharmaceutical analysis: understanding the differences and similarities
between validation requirements of the US Food and Drug Administration, the
US Pharmacopeia and the International Conference on Harmonization, J.
Chromatogr. A 987 (2003) 57–66.
[32] United States Pharmacopoeia 28-NF 23. United States Pharmacopoeia
Convention Inc., Rockville, MD 2005.
[33] J.C. Miller, J.N. Miller, Statistics for Analytical Chemistry, 22, Ellis Horwood,
Chichester, 1984.
[34] R. Causon, Validation of chromatographic methods in biomedical analysis
viewpoint and discussion, J. Chromatogr. B 689 (1997) 175–180.
[35] O. Abdel Razak, Electrochemical study of hydrochlorothiazide and its
determination in urine and tablets, J. Pharm. Biomed. Anal. 34 (2004) 433–440.
[36] E. Hamam, Reduced intensity preparative regimens for allogeneic
hematopoietic stem cell transplantation: a single center experience, J.
Pharm. Biomed. Anal. 30 (2002) 651–659.
[37] M.M. Ghoniem, K.Y. El-Baradie, A. Tawﬁk, Electrochemical behavior of the
antituberculosis drug isoniazid and its square-wave adsorptive stripping
voltammetric estimation in bulk form, tablets and biological ﬂuids at a
mercury electrode, J. Pharm. Biomed. Anal. 33 (2003) 673–685.
[38] A.J. Bard, L.R. Faulker, Electrochemical Methods: Fundamentals and
applications, John Wiley & Sons Inc., New York, 2002.
[39] E. Laviron, A multilayer model for the study of space distributed redox
modiﬁed electrodes: Part II. Theory and application of linear potential sweep
voltammetry for simple reaction, J. Electroanal. Chem. 52 (1974) 355–393.
[40] Q. Li, X. Liu, Polarographic behaviour of antiepilepsirine and its application,
Anal. Chim. Acta 258 (1992) 171–176.
